GlassScriptPhysician profile
Benjamin J Leeman
NPI 1174513998
$2,619.16
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $724 · 2021: $607 · 2022: $299 · 2023: $209 · 2024: $44.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $960.06 | 2019-2024 | Prolastin-C Liquid |
| Philips North America LLC | $623.29 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $279.85 | 2019-2021 | |
| Advanced Respiratory, INC | $168.86 | 2019-2021 | |
| Glaxosmithkline, LLC. | $160.68 | 2019-2021 | |
| Baxter Healthcare | $137.92 | 2022-2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $126.63 | 2019-2023 | Smartvest |
| Astrazeneca Pharmaceuticals LP | $86.90 | 2019-2021 | |
| Gilead Sciences, INC. | $30.56 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.38 | 2021 | |
| Phadia US INC. | $13.72 | 2019 | |
| Circassia INC. | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Leeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.